Effects of L-thyroxine suppressive therapy on bone mineral density

Annals of Medical Sciences

Volumn 11, Issue 1, 2002, Pages 21-24

  Sert, Murat ^a   Tetiker, Tamer ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Bone mineral; Euthyroid goiter; L thyroxine suppressive therapy

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; EUTHYROIDISM; FEMALE; FEMUR; FEMUR NECK; HUMAN; LUMBAR SPINE; MALE; NODULAR GOITER; OSTEOPENIA; PREMENOPAUSE; PROSPECTIVE STUDY; THYROTROPIN BLOOD LEVEL;

EID: 0036211030     PISSN: 13000683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Long-term changes in nodular goiter: A 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules
2. Medical teratment of benign thyroid nodules: Have we defined a benefit?
3. Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma
4. Possible limited bone loss with suppressive thyroxine therapy is unlikely to have clinical relevance
5. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine
6. A therapeutic dilemma: Suppressive doses of thyroxine significantly reduce bone mineral measurments in both premenopausal and post-menopausal women with thyroid carcinoma
7. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women
8. Ikiden fazla ortalamanin karşilaştinlmasi
9. Thyroid nodules and nodular thyroids: A clinical overview
10. Clinical review 66: Thyroxin suppression therapy for benign nodular disease
11. Thyroid nodule suppression
12. Evaluation and management of the solid thyroid nodule
13. Thyroxine suppressive therapy in patients with nodular thyroid disease
14. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre-and postmenopausal women with nontoxic goiter
15. Randomized trial of pamidronate in patients with thyroid cancer: Bone density is not reduce by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate
16. Longitudinal study of bone loss after thyroidectomy and suppressive thyroxine therapy in premenopausal women
17. A longitudinal assesment of bone loss in women with levothyroxine-suppressed benign thyroid disease and thyroid cancer
18. Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy
19. Bone mineral density in patients with endogenous subclinical hyperthyroidism: Is this thyroid status a risk factor for osteoporosis?
20. Changes in bone mineral density of the proximal femur and spine with aging
21. Thyroid supplements: Effect on bone mass
22. Simple radiological demonstration of cortical bone loss in thyrotoxicosis